Delineating MT-ATP6-associated disease: From isolated neuropathy to early onset neurodegeneration.
Claudia StendelChristiane M NeuhoferElisa FlorideShi YuqingRebecca D GanetzkyJoohyun ParkPeter FreisingerCornelia KornblumStephanie KleinleLudger SchölsFelix DistelmaierGeorg M StettnerBoriana BüchnerMarni J FalkJohannes Adalbert MayrMatthis SynofzikAngela AbichtTobias B HaackHolger ProkischSaskia B WortmannKei MurayamaFang FangThomas Klopstocknull nullPublished in: Neurology. Genetics (2020)
In this currently largest series of patients with mitochondrial MT-ATP6 mutations, the phenotypic spectrum ranged from asymptomatic to early onset multisystemic neurodegeneration. The degree of mutation heteroplasmy did not reliably predict disease severity. Leigh syndrome was found in more than half of the patients, whereas classic NARP syndrome was rare. Oligosymptomatic presentations were rather frequent in adult-onset patients, indicating the need to include MT-ATP6 mutations in the differential diagnosis of both ataxias and neuropathies.